Publish date: 10 February 2022
The first patient in the UK to receive a ‘vaccine’ that is hoped will stop his recurring head and neck cancer from returning is from Merseyside.
The clinical research team at The Clatterbridge Cancer Centre has given patient Graham Booth an injection of a therapy tailor-made to his personal DNA and designed to help his own immune system ward off cancer permanently.
Graham first had head and neck cancer in 2011 and it then returned four times, each time meaning he needed gruelling treatment, including facial surgery, reconstruction and radiotherapy. He is now hoping this new treatment – part of the Transgene clinical research study – will mean it does not come back.
You can read an ITV article on this, with video, here.